Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exploratory Study of DHA in Systemic Lupus Erythematosus Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03396393
Recruitment Status : Not yet recruiting
First Posted : January 11, 2018
Last Update Posted : January 23, 2018
Sponsor:
Information provided by (Responsible Party):
Kunming Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2022